Cartilage Repair/ Cartilage Regeneration Market by Treatment modalities (Cell based Type (Chondrocyte Transplantation, Growth Factor), Non-Cell (Tissue Scaffolds)), Application (Hyaline), End User (ASCs, Clinic), Site (Knee) - Global Forecast to 2025
The global cartilage repair and regeneration market is projected to reach USD 1,603 million by 2025 from USD 787 million in 2020, at a CAGR of 15.3% during the forecast period. The growth of this market is primarily driven by the increasing incidence of osteoarthritis and increasing funding and investments for research in this field.
“By cell-based treatment modality, the chondrocyte transplantation segment accounted for the largest share of the cartilage repair and regeneration market”
Based on the treatment modality, the cartilage repair and regeneration market is segmented into cell-based and non-cell-based approaches. The cell-based segment is further divided into chondrocyte transplantation, growth factors, and stem cells. The chondrocyte transplantation segment accounted for the largest share of this market in 2019, owing to greater longevity and utility for larger lesions.
“By application site segment, the knee segment accounted for the fastest growing segment of the cartilage repair and regeneration market”
Based on the application site, the cartilage repair and regeneration market is segmented into knee, hip, ankle and foot, and other application sites (nose and shoulder). The knee segment is estimated to be the fastest growing application site segment of the global cartilage repair and regeneration market. This can be attributed to the growing number of knee arthroscopy procedures and the increasing incidence of knee osteoarthritis.
“Asia Pacific: The fastest-growing region in the cartilage repair and regeneration market.”
The Asia Pacific region is estimated to grow at the highest CAGR in the cartilage repair and regeneration market during the forecast period, this is mainly due to the rising geriatric population and the subsequent increase in the incidence of various disorders and injuries. Recent developments in tissue engineering and stem cell therapy will further fuel market growth.
“North America: the largest share of the cartilage repair and regeneration market”
North America accounted for the largest share of the global market, followed by Europe. The large share of the North American region can be attributed to the high burden of osteoarthritis, increasing prevalence of sports injuries, and increasing research investments in the US and Canada.
Breakdown of primaries
The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:
Research Coverage:
The report segments the cartilage repair and regeneration market based on region (Asia Pacific, Europe, North America, and RoW), Treatment Modality (cell-based and non-cell-based approaches), Application (hyaline cartilage and fibrocartilage), End User (hospitals and ambulatory surgery centers & clinics) and Application Site (knee, hip, ankle and foot, nose, and shoulder). The report also provides a comprehensive review of market drivers, restraints, opportunities, challenges and trends in the cartilage repair and regeneration market.
Key Benefits of Buying the Report:
The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the cartilage repair and regeneration market and provides them information on key market drivers, restraints, challenges, and opportunities.
“By cell-based treatment modality, the chondrocyte transplantation segment accounted for the largest share of the cartilage repair and regeneration market”
Based on the treatment modality, the cartilage repair and regeneration market is segmented into cell-based and non-cell-based approaches. The cell-based segment is further divided into chondrocyte transplantation, growth factors, and stem cells. The chondrocyte transplantation segment accounted for the largest share of this market in 2019, owing to greater longevity and utility for larger lesions.
“By application site segment, the knee segment accounted for the fastest growing segment of the cartilage repair and regeneration market”
Based on the application site, the cartilage repair and regeneration market is segmented into knee, hip, ankle and foot, and other application sites (nose and shoulder). The knee segment is estimated to be the fastest growing application site segment of the global cartilage repair and regeneration market. This can be attributed to the growing number of knee arthroscopy procedures and the increasing incidence of knee osteoarthritis.
“Asia Pacific: The fastest-growing region in the cartilage repair and regeneration market.”
The Asia Pacific region is estimated to grow at the highest CAGR in the cartilage repair and regeneration market during the forecast period, this is mainly due to the rising geriatric population and the subsequent increase in the incidence of various disorders and injuries. Recent developments in tissue engineering and stem cell therapy will further fuel market growth.
“North America: the largest share of the cartilage repair and regeneration market”
North America accounted for the largest share of the global market, followed by Europe. The large share of the North American region can be attributed to the high burden of osteoarthritis, increasing prevalence of sports injuries, and increasing research investments in the US and Canada.
Breakdown of primaries
The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:
- By Respondent– Supply Side- 80%, Demand Side-20%
- By Designation— CXOs - 20%, Executives - 25%, Mangers - 55%
- By Region— North America - 50%, Europe - 20%, APAC – 20%, RoW- 10%
Research Coverage:
The report segments the cartilage repair and regeneration market based on region (Asia Pacific, Europe, North America, and RoW), Treatment Modality (cell-based and non-cell-based approaches), Application (hyaline cartilage and fibrocartilage), End User (hospitals and ambulatory surgery centers & clinics) and Application Site (knee, hip, ankle and foot, nose, and shoulder). The report also provides a comprehensive review of market drivers, restraints, opportunities, challenges and trends in the cartilage repair and regeneration market.
Key Benefits of Buying the Report:
The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the cartilage repair and regeneration market and provides them information on key market drivers, restraints, challenges, and opportunities.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
TABLE 1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
FIGURE 1 MARKETS COVERED
1.3.1 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 2 BREAKDOWN OF PRIMARIES: CARTILAGE REPAIR AND REGENERATION MARKET
2.1.3 MARKET DATA ESTIMATION & TRIANGULATION
2.1.3.1 Data Triangulation
FIGURE 3 DATA TRIANGULATION METHODOLOGY
2.2 MARKET ESTIMATION METHODOLOGY
FIGURE 4 MARKET SIZE ESTIMATION APPROACH 1: COMPANY REVENUE ANALYSIS-BASED ESTIMATION
FIGURE 5 MARKET SIZE ESTIMATION APPROACH 2: TOP-DOWN APPROACH
FIGURE 6 CARTILAGE REPAIR AND REGENERATION MARKET SIZE (USD MILLION)
2.3 GROWTH RATE ASSUMPTIONS/GROWTH FORECAST
FIGURE 7 SEGMENTAL GROWTH RATE OF COMPANIES (2015?2019)
FIGURE 8 FINAL CAGR PROJECTIONS (2020?2025)
FIGURE 9 CAGR PROJECTIONS FROM THE ANALYSIS OF DEMAND-SIDE DRIVERS AND OPPORTUNITIES
2.4 INSIGHTS FROM PRIMARIES
FIGURE 10 MARKET VALIDATION FROM PRIMARY EXPERTS
2.5 RESEARCH ASSUMPTIONS
2.6 RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT
3 EXECUTIVE SUMMARY
FIGURE 11 CARTILAGE REPAIR AND REGENERATION MARKET, BY TREATMENT MODALITY
FIGURE 12 CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION SITE, 2020—2025
FIGURE 13 CARTILAGE REPAIR AND REGENERATION MARKET SHARE, BY END USER, 2019
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF THE CARTILAGE REPAIR AND
REGENERATION MARKET
4 PREMIUM INSIGHTS
4.1 CARTILAGE REPAIR AND REGENERATION MARKET OVERVIEW
FIGURE 15 RISING INCIDENCE OF OSTEOARTHRITIS TO DRIVE MARKET GROWTH
4.2 ASIA PACIFIC: CARTILAGE REPAIR AND REGENERATION MARKET, BY TREATMENT MODALITY AND COUNTRY (2019)
FIGURE 16 CELL-BASED SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE
ASIA PACIFIC MARKET IN 2019
4.3 CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY TYPE (2020–2025)
FIGURE 17 CHONDROCYTE TRANSPLANTATION SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN THE FORECAST PERIOD
4.4 CARTILAGE REPAIR AND REGENERATION MARKET SHARE, BY APPLICATION, 2020 VS. 2025
FIGURE 18 HYALINE CARTILAGE IS THE LARGEST APPLICATION SEGMENT OF THE CARTILAGE REPAIR AND REGENERATION MARKET
4.5 CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION SITE, 2020 VS. 2025 (USD MILLION)
FIGURE 19 THE KNEE SEGMENT WILL CONTINUE TO DOMINATE THE CARTILAGE REPAIR AND REGENERATION MARKET IN 2025
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 20 CARTILAGE REPAIR AND REGENERATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 MARKET DRIVERS
5.2.1.1 Increasing incidence of osteoarthritis
5.2.1.2 Increasing research funding and investments
5.2.2 RESTRAINTS
5.2.2.1 High cost of cartilage repair surgeries
5.2.3 OPPORTUNITIES
5.2.3.1 Technological advancements
5.2.4 CHALLENGES
5.2.4.1 Limitation of cartilage-based stem cell products
5.3 SUPPLY CHAIN ANALYSIS
FIGURE 21 SUPPLY CHAIN ANALYSIS OF THE CARTILAGE REPAIR AND
REGENERATION MARKET
5.4 IMPACT OF THE COVID-19 OUTBREAK ON THE GROWTH OF THE CARTILAGE REPAIR AND REGENERATION MARKET
FIGURE 22 COVID-19 IMPACT ON THE CARTILAGE REPAIR AND REGENERATION MARKET
5.5 REGULATORY ASSESSMENT
5.5.1 INTRODUCTION
5.5.2 NORTH AMERICA
5.5.3 EUROPE
5.5.4 ASIA PACIFIC
5.6 PATENT ANALYSIS
5.6.1 DOCUMENT TYPE
TABLE 3 PATENTS FILED
FIGURE 23 PATENTS FILED (2016—2020)
FIGURE 24 PATENTS FILED BETWEEN 2016 AND AUGUST 2020
5.6.2 INSIGHTS
FIGURE 25 JURISDICTION ANALYSIS (2019)
5.6.3 TOP APPLICANTS (2019)
5.7 PIPELINE ANALYSIS
5.7.1 BASED ON THE PHASE OF CLINICAL TRIAL
FIGURE 26 MAJORITY OF CARTILAGE REPAIR CANDIDATE PRODUCTS ARE IN PHASE 3
5.8 TECHNOLOGY ANALYSIS
6 CARTILAGE REPAIR AND REGENERATION MARKET, BY TREATMENT MODALITY
6.1 INTRODUCTION
TABLE 4 CARTILAGE REPAIR AND REGENERATION MARKET, BY TREATMENT MODALITY, 2018–2025 (USD MILLION)
6.2 CELL-BASED
TABLE 5 CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 6 CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY REGION, 2018–2025 (USD MILLION)
TABLE 7 NORTH AMERICA: CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 8 EUROPE: CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 9 APAC: CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY COUNTRY, 2018–2025 (USD MILLION)
6.2.1 CHONDROCYTE TRANSPLANTATION
6.2.1.1 Cost-effectiveness of chondrocyte transplantation to support market growth
TABLE 10 CHONDROCYTE TRANSPLANTATION MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 11 NORTH AMERICA: CHONDROCYTE TRANSPLANTATION MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.2.2 GROWTH FACTORS
6.2.2.1 Promising results associated with growth factors is the major factor driving the growth of this segment
TABLE 12 GROWTH FACTORS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 13 NORTH AMERICA: GROWTH FACTORS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.2.3 STEM CELLS
6.2.3.1 Advancements in stem cell-based tissue engineering will drive the growth of this segment
TABLE 14 STEM CELLS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 15 NORTH AMERICA: STEM CELLS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.3 NON-CELL-BASED
TABLE 16 CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 17 CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY REGION, 2018–2025 (USD MILLION)
TABLE 18 NORTH AMERICA: CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 19 EUROPE: CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 20 APAC: CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY COUNTRY, 2018–2025 (USD MILLION)
6.3.1 TISSUE SCAFFOLDS
6.3.1.1 Benefits of the one-step procedure likely to boost the market growth
TABLE 21 TISSUE SCAFFOLDS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.3.2 CELL-FREE COMPOSITES
6.3.2.1 Increasing research to support market growth
TABLE 22 CELL-FREE COMPOSITES MARKET, BY REGION, 2018–2025 (USD MILLION)
7 CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION SITE
7.1 INTRODUCTION
TABLE 23 CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION SITE, 2018–2025 (USD MILLION)
7.2 KNEE
7.2.1 INCREASING CASES OF KNEE ARTHROSCOPY TO DRIVE MARKET GROWTH
TABLE 24 CARTILAGE REPAIR AND REGENERATION MARKET FOR KNEE, BY REGION, 2018–2025 (USD MILLION)
TABLE 25 NORTH AMERICA: CARTILAGE REPAIR AND REGENERATION MARKET FOR KNEE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 26 EUROPE: CARTILAGE REPAIR AND REGENERATION MARKET FOR KNEE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 27 APAC: CARTILAGE REPAIR AND REGENERATION MARKET FOR KNEE, BY COUNTRY, 2018–2025 (USD MILLION)
7.3 HIP
7.3.1 INCREASING ADOPTION OF MINIMALLY INVASIVE ARTHROSCOPY PROCEDURES TO SUPPORT MARKET GROWTH
TABLE 28 CARTILAGE REPAIR AND REGENERATION MARKET FOR HIP, BY REGION, 2018–2025 (USD MILLION)
TABLE 29 NORTH AMERICA: CARTILAGE REPAIR AND REGENERATION MARKET FOR HIP, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 30 EUROPE: CARTILAGE REPAIR AND REGENERATION MARKET FOR HIP, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 31 APAC: CARTILAGE REPAIR AND REGENERATION MARKET FOR HIP, BY COUNTRY, 2018–2025 (USD MILLION)
7.4 ANKLE & FOOT
7.4.1 INCREASING SPORTS INJURIES IN THE ANKLE & FOOT ARE LIKELY TO DRIVE THE DEMAND FOR CARTILAGE REPAIR PROCEDURES
TABLE 32 CARTILAGE REPAIR AND REGENERATION MARKET FOR ANKLE & FOOT, BY REGION, 2018–2025 (USD MILLION)
TABLE 33 NORTH AMERICA: CARTILAGE REPAIR AND REGENERATION MARKET FOR ANKLE & FOOT, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 34 EUROPE: CARTILAGE REPAIR AND REGENERATION MARKET FOR ANKLE & FOOT, BY COUNTRY, 2018–2025 (USD MILLION)
7.5 OTHER APPLICATION SITES
TABLE 35 CARTILAGE REPAIR AND REGENERATION MARKET FOR OTHER APPLICATION SITES, BY REGION, 2018–2025 (USD MILLION)
TABLE 36 NORTH AMERICA: CARTILAGE REPAIR AND REGENERATION MARKET FOR OTHER APPLICATION SITES, BY COUNTRY, 2018–2025 (USD MILLION)
8 CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION
8.1 INTRODUCTION
TABLE 37 CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
8.2 HYALINE CARTILAGE
8.2.1 HYALINE CARTILAGE SEGMENT HOLDS THE LARGER MARKET SHARE
TABLE 38 HYALINE CARTILAGE REPAIR AND REGENERATION MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 39 NORTH AMERICA: HYALINE CARTILAGE REPAIR AND REGENERATION MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 40 EUROPE: HYALINE CARTILAGE REPAIR AND REGENERATION MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 41 APAC: HYALINE CARTILAGE REPAIR AND REGENERATION MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
8.3 FIBROCARTILAGE
8.3.1 FIBROCARTILAGE PROVIDES SUPPORT AND RIGIDITY TO SURROUNDING STRUCTURES
TABLE 42 FIBROCARTILAGE REPAIR AND REGENERATION MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 43 NORTH AMERICA: FIBROCARTILAGE REPAIR AND REGENERATION MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 44 EUROPE: FIBROCARTILAGE REPAIR AND REGENERATION MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 45 APAC: FIBROCARTILAGE REPAIR AND REGENERATION MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
9 CARTILAGE REPAIR AND REGENERATION MARKET, BY END USER
9.1 INTRODUCTION
TABLE 46 CARTILAGE REPAIR AND REGENERATION MARKET, BY END USER, 2018–2025 (USD MILLION)
9.2 HOSPITALS
9.2.1 HOSPITALS ARE THE LARGEST & FASTEST-GROWING END USERS
OF THE MARKET
TABLE 47 CARTILAGE REPAIR AND REGENERATION MARKET FOR HOSPITALS, BY REGION, 2018–2025 (USD MILLION)
TABLE 48 NORTH AMERICA: CARTILAGE REPAIR AND REGENERATION MARKET
FOR HOSPITALS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 49 EUROPE: CARTILAGE REPAIR AND REGENERATION MARKET FOR HOSPITALS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 50 APAC: CARTILAGE REPAIR AND REGENERATION MARKET FOR HOSPITALS, BY COUNTRY, 2018–2025 (USD MILLION)
9.3 AMBULATORY SURGERY CENTERS & CLINICS
9.3.1 RISING PREFERENCE FOR PERFORMING SURGERIES IN ASCS IS SUPPORTING THE GROWTH OF THIS SEGMENT
TABLE 51 CARTILAGE REPAIR AND REGENERATION MARKET FOR ASCS & CLINICS, BY REGION, 2018–2025 (USD MILLION)
TABLE 52 NORTH AMERICA: CARTILAGE REPAIR AND REGENERATION MARKET FOR ASCS & CLINICS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 53 EUROPE: CARTILAGE REPAIR AND REGENERATION MARKET FOR ASCS & CLINICS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 54 APAC: CARTILAGE REPAIR AND REGENERATION MARKET FOR ASCS & CLINICS, BY COUNTRY, 2018–2025 (USD MILLION)
10 CARTILAGE REPAIR AND REGENERATION MARKET, BY REGION
10.1 INTRODUCTION
FIGURE 27 CARTILAGE REPAIR AND REGENERATION MARKET, BY REGION, 2020 VS. 2025 (USD MILLION)
TABLE 55 CARTILAGE REPAIR AND REGENERATION MARKET, BY REGION, 2018–2025 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 28 NORTH AMERICA: CARTILAGE REPAIR AND REGENERATION MARKET SNAPSHOT
TABLE 56 NORTH AMERICA: CARTILAGE REPAIR AND REGENERATION MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 57 NORTH AMERICA: CARTILAGE REPAIR AND REGENERATION MARKET, BY TREATMENT MODALITY, 2018–2025 (USD MILLION)
TABLE 58 NORTH AMERICA: CARTILAGE REPAIR AND REGENERATION MARKET
FOR CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 59 NORTH AMERICA: CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 60 NORTH AMERICA: CARTILAGE REPAIR AND REGENERATION MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 61 NORTH AMERICA: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 62 NORTH AMERICA: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION SITE, 2018–2025(USD MILLION)
10.2.1 US
10.2.1.1 Increasing incidence of obesity is the major factor supporting the market growth in the US
TABLE 63 US: CARTILAGE REPAIR AND REGENERATION MARKET, BY TREATMENT MODALITY, 2018–2025 (USD MILLION)
TABLE 64 US: CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 65 US: CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 66 US: CARTILAGE REPAIR AND REGENERATION MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 67 US: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 68 US: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION SITE, 2018–2025 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Increasing investments in regenerative medicine research to drive market growth
TABLE 69 CANADA: CARTILAGE REPAIR AND REGENERATION MARKET, BY TREATMENT MODALITY, 2018–2025 (USD MILLION)
TABLE 70 CANADA: CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 71 CANADA: CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 72 CANADA: CARTILAGE REPAIR AND REGENERATION MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 73 CANADA: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 74 CANADA: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION SITE, 2018–2025 (USD MILLION)
10.3 EUROPE
TABLE 75 EUROPE: CARTILAGE REPAIR AND REGENERATION MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 76 EUROPE: CARTILAGE REPAIR AND REGENERATION MARKET, BY TREATMENT MODALITY, 2018–2025 (USD MILLION)
TABLE 77 EUROPE: CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 78 EUROPE: CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 79 EUROPE: CARTILAGE REPAIR AND REGENERATION MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 80 EUROPE: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 81 EUROPE: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION SITE, 2018–2025 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Strong R&D base and focus on minimally invasive surgeries to support market growth
TABLE 82 GERMANY: CARTILAGE REPAIR AND REGENERATION MARKET, BY TREATMENT MODALITY, 2018–2025 (USD MILLION)
TABLE 83 GERMANY: CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 84 GERMANY: CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 85 GERMANY: CARTILAGE REPAIR AND REGENERATION MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 86 GERMANY: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 87 GERMANY: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION SITE, 2018–2025 (USD MILLION)
10.3.2 UK
10.3.2.1 Rising number of clinical trials in the UK to drive market growth
TABLE 88 UK: CARTILAGE REPAIR AND REGENERATION PRODUCTS UNDER CLINICAL TRIALS
TABLE 89 UK: CARTILAGE REPAIR AND REGENERATION MARKET, BY TREATMENT MODALITY, 2018–2025 (USD MILLION)
TABLE 90 UK: CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 91 UK: CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 92 UK: CARTILAGE REPAIR AND REGENERATION MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 93 UK: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 94 UK: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION SITE, 2018–2025 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 Rising healthcare expenditure in the country to drive market growth
TABLE 95 FRANCE: CARTILAGE REPAIR AND REGENERATION MARKET, BY TREATMENT MODALITY, 2018–2025 (USD MILLION)
TABLE 96 FRANCE: CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 97 FRANCE: CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 98 FRANCE: CARTILAGE REPAIR AND REGENERATION MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 99 FRANCE: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 100 FRANCE: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION SITE, 2018–2025 (USD MILLION)
10.3.4 REST OF EUROPE
TABLE 101 ROE: CARTILAGE REPAIR AND REGENERATION MARKET, BY TREATMENT MODALITY, 2018–2025 (USD MILLION)
TABLE 102 ROE: CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 103 ROE: CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 104 ROE: CARTILAGE REPAIR AND REGENERATION MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 105 ROE: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 106 ROE: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION SITE, 2018–2025 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 29 ASIA PACIFIC: CARTILAGE REPAIR AND REGENERATION MARKET
TABLE 107 APAC: CARTILAGE REPAIR AND REGENERATION MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 108 APAC: CARTILAGE REPAIR AND REGENERATION MARKET, BY TREATMENT MODALITY, 2018–2025 (USD MILLION)
TABLE 109 APAC: CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 110 APAC: CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 111 APAC: CARTILAGE REPAIR AND REGENERATION MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 112 APAC: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 113 APAC: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION SITE, 2018–2025 (USD MILLION)
10.4.1 JAPAN
10.4.1.1 Rising geriatric population is the major factor supporting market growth in Japan
TABLE 114 JAPAN: CARTILAGE REPAIR AND REGENERATION MARKET, BY TREATMENT MODALITY, 2018–2025 (USD MILLION)
TABLE 115 JAPAN: CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 116 JAPAN: CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 117 JAPAN: CARTILAGE REPAIR AND REGENERATION MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 118 JAPAN: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 119 JAPAN: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION SITE, 2018–2025 (USD MILLION)
10.4.2 CHINA
10.4.2.1 China forms the fastest-growing market in the APAC
TABLE 120 CHINA: CARTILAGE REPAIR AND REGENERATION MARKET, BY TREATMENT MODALITY, 2018–2025 (USD MILLION)
TABLE 121 CHINA: CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 122 CHINA: CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 123 CHINA: CARTILAGE REPAIR AND REGENERATION MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 124 CHINA: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 125 CHINA: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION SITE, 2018–2025 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Medical tourism will propel market growth in India
TABLE 126 INDIA: CARTILAGE REPAIR AND REGENERATION MARKET, BY TREATMENT MODALITY, 2018–2025 (USD MILLION)
TABLE 127 INDIA: CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 128 INDIA: CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 129 INDIA: CARTILAGE REPAIR AND REGENERATION MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 130 INDIA: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 131 INDIA: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION SITE, 2018–2025 (USD MILLION)
10.4.4 REST OF ASIA PACIFIC
TABLE 132 ROAPAC: CARTILAGE REPAIR AND REGENERATION MARKET, BY TREATMENT MODALITY, 2018–2025 (USD MILLION)
TABLE 133 ROAPAC: CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 134 ROAPAC: CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 135 ROAPAC: CARTILAGE REPAIR AND REGENERATION MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 136 ROAPAC: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 137 ROAPAC: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION SITE, 2018–2025 (USD MILLION)
10.5 REST OF THE WORLD
TABLE 138 ROW: CARTILAGE REPAIR AND REGENERATION MARKET, BY TREATMENT MODALITY, 2018–2025 (USD MILLION)
TABLE 139 ROW: CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 140 ROW: CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 141 ROW: CARTILAGE REPAIR AND REGENERATION MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 142 ROW: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 143 ROW: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION SITE, 2018–2025 (USD MILLION)
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 MARKET RANKING ANALYSIS
FIGURE 30 CARTILAGE REPAIR AND REGENERATION MARKET RANKING, 2019
11.2.1 MARKET REVENUE ANALYSIS (2015–2019)
FIGURE 31 REVENUE ANALYSIS OF MAJOR PLAYERS (2015?2019)
11.3 MARKET EVALUATION FRAMEWORK
TABLE 144 MARKET EVALUATION FRAMEWORK: PRODUCT LAUNCH—THE MAJOR STRATEGY ADOPTED BY PLAYERS
11.4 COMPETITIVE SCENARIO
11.4.1 KEY PRODUCT LAUNCHES
11.4.2 KEY ACQUISITIONS
11.4.3 KEY COLLABORATIONS
11.4.4 KEY EXPANSIONS
11.5 COMPANY EVALUATION MATRIX
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PARTICIPANTS
11.5.4 PERVASIVE
FIGURE 32 CARTILAGE REPAIR AND REGENERATION MARKET:
COMPETITIVE EVALUATION MATRIX (2019)
12 COMPANY PROFILES
(Business overview, Products offered, Recent Developments, SWOT analysis, MNM view)*
12.1 SMITH & NEPHEW PLC
FIGURE 33 SMITH & NEPHEW: COMPANY SNAPSHOT (2019)
12.2 DEPUY SYNTHES
FIGURE 34 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2019)
12.3 ZIMMER BIOMET HOLDINGS, INC.
FIGURE 35 ZIMMER BIOMET: COMPANY SNAPSHOT (2019)
12.4 STRYKER CORPORATION
FIGURE 36 STRYKER CORPORATION: COMPANY SNAPSHOT (2019)
12.5 VERICEL CORPORATION
FIGURE 37 VERICEL CORPORATION: COMPANY SNAPSHOT (2019)
12.6 B. BRAUN MELSUNGEN AG
FIGURE 38 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2019)
12.7 ANIKA THERAPEUTICS
FIGURE 39 ANIKA THERAPEUTICS: COMPANY SNAPSHOT (2019)
12.8 RTI SURGICAL
12.9 CONMED CORPORATION
FIGURE 40 CONMED CORPORATION: COMPANY SNAPSHOT (2019)
12.10 ARTHREX, INC.
12.11 REGROW BIOSCIENCES
12.12 MEDIPOST
FIGURE 41 MEDIPOST: COMPANY SNAPSHOT (2019)
12.13 GEISTLICH PHARMA AG
12.14 ALLOSOURCE
12.15 ORTHOCELL LTD.
12.16 BIOTISSUE SA
*Details on Business overview, Products offered, Recent Developments, SWOT analysis, MNM view might not be captured in case of unlisted companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
TABLE 1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
FIGURE 1 MARKETS COVERED
1.3.1 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 2 BREAKDOWN OF PRIMARIES: CARTILAGE REPAIR AND REGENERATION MARKET
2.1.3 MARKET DATA ESTIMATION & TRIANGULATION
2.1.3.1 Data Triangulation
FIGURE 3 DATA TRIANGULATION METHODOLOGY
2.2 MARKET ESTIMATION METHODOLOGY
FIGURE 4 MARKET SIZE ESTIMATION APPROACH 1: COMPANY REVENUE ANALYSIS-BASED ESTIMATION
FIGURE 5 MARKET SIZE ESTIMATION APPROACH 2: TOP-DOWN APPROACH
FIGURE 6 CARTILAGE REPAIR AND REGENERATION MARKET SIZE (USD MILLION)
2.3 GROWTH RATE ASSUMPTIONS/GROWTH FORECAST
FIGURE 7 SEGMENTAL GROWTH RATE OF COMPANIES (2015?2019)
FIGURE 8 FINAL CAGR PROJECTIONS (2020?2025)
FIGURE 9 CAGR PROJECTIONS FROM THE ANALYSIS OF DEMAND-SIDE DRIVERS AND OPPORTUNITIES
2.4 INSIGHTS FROM PRIMARIES
FIGURE 10 MARKET VALIDATION FROM PRIMARY EXPERTS
2.5 RESEARCH ASSUMPTIONS
2.6 RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT
3 EXECUTIVE SUMMARY
FIGURE 11 CARTILAGE REPAIR AND REGENERATION MARKET, BY TREATMENT MODALITY
FIGURE 12 CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION SITE, 2020—2025
FIGURE 13 CARTILAGE REPAIR AND REGENERATION MARKET SHARE, BY END USER, 2019
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF THE CARTILAGE REPAIR AND
REGENERATION MARKET
4 PREMIUM INSIGHTS
4.1 CARTILAGE REPAIR AND REGENERATION MARKET OVERVIEW
FIGURE 15 RISING INCIDENCE OF OSTEOARTHRITIS TO DRIVE MARKET GROWTH
4.2 ASIA PACIFIC: CARTILAGE REPAIR AND REGENERATION MARKET, BY TREATMENT MODALITY AND COUNTRY (2019)
FIGURE 16 CELL-BASED SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE
ASIA PACIFIC MARKET IN 2019
4.3 CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY TYPE (2020–2025)
FIGURE 17 CHONDROCYTE TRANSPLANTATION SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN THE FORECAST PERIOD
4.4 CARTILAGE REPAIR AND REGENERATION MARKET SHARE, BY APPLICATION, 2020 VS. 2025
FIGURE 18 HYALINE CARTILAGE IS THE LARGEST APPLICATION SEGMENT OF THE CARTILAGE REPAIR AND REGENERATION MARKET
4.5 CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION SITE, 2020 VS. 2025 (USD MILLION)
FIGURE 19 THE KNEE SEGMENT WILL CONTINUE TO DOMINATE THE CARTILAGE REPAIR AND REGENERATION MARKET IN 2025
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 20 CARTILAGE REPAIR AND REGENERATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 MARKET DRIVERS
5.2.1.1 Increasing incidence of osteoarthritis
5.2.1.2 Increasing research funding and investments
5.2.2 RESTRAINTS
5.2.2.1 High cost of cartilage repair surgeries
5.2.3 OPPORTUNITIES
5.2.3.1 Technological advancements
5.2.4 CHALLENGES
5.2.4.1 Limitation of cartilage-based stem cell products
5.3 SUPPLY CHAIN ANALYSIS
FIGURE 21 SUPPLY CHAIN ANALYSIS OF THE CARTILAGE REPAIR AND
REGENERATION MARKET
5.4 IMPACT OF THE COVID-19 OUTBREAK ON THE GROWTH OF THE CARTILAGE REPAIR AND REGENERATION MARKET
FIGURE 22 COVID-19 IMPACT ON THE CARTILAGE REPAIR AND REGENERATION MARKET
5.5 REGULATORY ASSESSMENT
5.5.1 INTRODUCTION
5.5.2 NORTH AMERICA
5.5.3 EUROPE
5.5.4 ASIA PACIFIC
5.6 PATENT ANALYSIS
5.6.1 DOCUMENT TYPE
TABLE 3 PATENTS FILED
FIGURE 23 PATENTS FILED (2016—2020)
FIGURE 24 PATENTS FILED BETWEEN 2016 AND AUGUST 2020
5.6.2 INSIGHTS
FIGURE 25 JURISDICTION ANALYSIS (2019)
5.6.3 TOP APPLICANTS (2019)
5.7 PIPELINE ANALYSIS
5.7.1 BASED ON THE PHASE OF CLINICAL TRIAL
FIGURE 26 MAJORITY OF CARTILAGE REPAIR CANDIDATE PRODUCTS ARE IN PHASE 3
5.8 TECHNOLOGY ANALYSIS
6 CARTILAGE REPAIR AND REGENERATION MARKET, BY TREATMENT MODALITY
6.1 INTRODUCTION
TABLE 4 CARTILAGE REPAIR AND REGENERATION MARKET, BY TREATMENT MODALITY, 2018–2025 (USD MILLION)
6.2 CELL-BASED
TABLE 5 CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 6 CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY REGION, 2018–2025 (USD MILLION)
TABLE 7 NORTH AMERICA: CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 8 EUROPE: CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 9 APAC: CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY COUNTRY, 2018–2025 (USD MILLION)
6.2.1 CHONDROCYTE TRANSPLANTATION
6.2.1.1 Cost-effectiveness of chondrocyte transplantation to support market growth
TABLE 10 CHONDROCYTE TRANSPLANTATION MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 11 NORTH AMERICA: CHONDROCYTE TRANSPLANTATION MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.2.2 GROWTH FACTORS
6.2.2.1 Promising results associated with growth factors is the major factor driving the growth of this segment
TABLE 12 GROWTH FACTORS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 13 NORTH AMERICA: GROWTH FACTORS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.2.3 STEM CELLS
6.2.3.1 Advancements in stem cell-based tissue engineering will drive the growth of this segment
TABLE 14 STEM CELLS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 15 NORTH AMERICA: STEM CELLS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.3 NON-CELL-BASED
TABLE 16 CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 17 CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY REGION, 2018–2025 (USD MILLION)
TABLE 18 NORTH AMERICA: CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 19 EUROPE: CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 20 APAC: CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY COUNTRY, 2018–2025 (USD MILLION)
6.3.1 TISSUE SCAFFOLDS
6.3.1.1 Benefits of the one-step procedure likely to boost the market growth
TABLE 21 TISSUE SCAFFOLDS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.3.2 CELL-FREE COMPOSITES
6.3.2.1 Increasing research to support market growth
TABLE 22 CELL-FREE COMPOSITES MARKET, BY REGION, 2018–2025 (USD MILLION)
7 CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION SITE
7.1 INTRODUCTION
TABLE 23 CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION SITE, 2018–2025 (USD MILLION)
7.2 KNEE
7.2.1 INCREASING CASES OF KNEE ARTHROSCOPY TO DRIVE MARKET GROWTH
TABLE 24 CARTILAGE REPAIR AND REGENERATION MARKET FOR KNEE, BY REGION, 2018–2025 (USD MILLION)
TABLE 25 NORTH AMERICA: CARTILAGE REPAIR AND REGENERATION MARKET FOR KNEE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 26 EUROPE: CARTILAGE REPAIR AND REGENERATION MARKET FOR KNEE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 27 APAC: CARTILAGE REPAIR AND REGENERATION MARKET FOR KNEE, BY COUNTRY, 2018–2025 (USD MILLION)
7.3 HIP
7.3.1 INCREASING ADOPTION OF MINIMALLY INVASIVE ARTHROSCOPY PROCEDURES TO SUPPORT MARKET GROWTH
TABLE 28 CARTILAGE REPAIR AND REGENERATION MARKET FOR HIP, BY REGION, 2018–2025 (USD MILLION)
TABLE 29 NORTH AMERICA: CARTILAGE REPAIR AND REGENERATION MARKET FOR HIP, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 30 EUROPE: CARTILAGE REPAIR AND REGENERATION MARKET FOR HIP, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 31 APAC: CARTILAGE REPAIR AND REGENERATION MARKET FOR HIP, BY COUNTRY, 2018–2025 (USD MILLION)
7.4 ANKLE & FOOT
7.4.1 INCREASING SPORTS INJURIES IN THE ANKLE & FOOT ARE LIKELY TO DRIVE THE DEMAND FOR CARTILAGE REPAIR PROCEDURES
TABLE 32 CARTILAGE REPAIR AND REGENERATION MARKET FOR ANKLE & FOOT, BY REGION, 2018–2025 (USD MILLION)
TABLE 33 NORTH AMERICA: CARTILAGE REPAIR AND REGENERATION MARKET FOR ANKLE & FOOT, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 34 EUROPE: CARTILAGE REPAIR AND REGENERATION MARKET FOR ANKLE & FOOT, BY COUNTRY, 2018–2025 (USD MILLION)
7.5 OTHER APPLICATION SITES
TABLE 35 CARTILAGE REPAIR AND REGENERATION MARKET FOR OTHER APPLICATION SITES, BY REGION, 2018–2025 (USD MILLION)
TABLE 36 NORTH AMERICA: CARTILAGE REPAIR AND REGENERATION MARKET FOR OTHER APPLICATION SITES, BY COUNTRY, 2018–2025 (USD MILLION)
8 CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION
8.1 INTRODUCTION
TABLE 37 CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
8.2 HYALINE CARTILAGE
8.2.1 HYALINE CARTILAGE SEGMENT HOLDS THE LARGER MARKET SHARE
TABLE 38 HYALINE CARTILAGE REPAIR AND REGENERATION MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 39 NORTH AMERICA: HYALINE CARTILAGE REPAIR AND REGENERATION MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 40 EUROPE: HYALINE CARTILAGE REPAIR AND REGENERATION MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 41 APAC: HYALINE CARTILAGE REPAIR AND REGENERATION MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
8.3 FIBROCARTILAGE
8.3.1 FIBROCARTILAGE PROVIDES SUPPORT AND RIGIDITY TO SURROUNDING STRUCTURES
TABLE 42 FIBROCARTILAGE REPAIR AND REGENERATION MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 43 NORTH AMERICA: FIBROCARTILAGE REPAIR AND REGENERATION MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 44 EUROPE: FIBROCARTILAGE REPAIR AND REGENERATION MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 45 APAC: FIBROCARTILAGE REPAIR AND REGENERATION MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
9 CARTILAGE REPAIR AND REGENERATION MARKET, BY END USER
9.1 INTRODUCTION
TABLE 46 CARTILAGE REPAIR AND REGENERATION MARKET, BY END USER, 2018–2025 (USD MILLION)
9.2 HOSPITALS
9.2.1 HOSPITALS ARE THE LARGEST & FASTEST-GROWING END USERS
OF THE MARKET
TABLE 47 CARTILAGE REPAIR AND REGENERATION MARKET FOR HOSPITALS, BY REGION, 2018–2025 (USD MILLION)
TABLE 48 NORTH AMERICA: CARTILAGE REPAIR AND REGENERATION MARKET
FOR HOSPITALS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 49 EUROPE: CARTILAGE REPAIR AND REGENERATION MARKET FOR HOSPITALS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 50 APAC: CARTILAGE REPAIR AND REGENERATION MARKET FOR HOSPITALS, BY COUNTRY, 2018–2025 (USD MILLION)
9.3 AMBULATORY SURGERY CENTERS & CLINICS
9.3.1 RISING PREFERENCE FOR PERFORMING SURGERIES IN ASCS IS SUPPORTING THE GROWTH OF THIS SEGMENT
TABLE 51 CARTILAGE REPAIR AND REGENERATION MARKET FOR ASCS & CLINICS, BY REGION, 2018–2025 (USD MILLION)
TABLE 52 NORTH AMERICA: CARTILAGE REPAIR AND REGENERATION MARKET FOR ASCS & CLINICS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 53 EUROPE: CARTILAGE REPAIR AND REGENERATION MARKET FOR ASCS & CLINICS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 54 APAC: CARTILAGE REPAIR AND REGENERATION MARKET FOR ASCS & CLINICS, BY COUNTRY, 2018–2025 (USD MILLION)
10 CARTILAGE REPAIR AND REGENERATION MARKET, BY REGION
10.1 INTRODUCTION
FIGURE 27 CARTILAGE REPAIR AND REGENERATION MARKET, BY REGION, 2020 VS. 2025 (USD MILLION)
TABLE 55 CARTILAGE REPAIR AND REGENERATION MARKET, BY REGION, 2018–2025 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 28 NORTH AMERICA: CARTILAGE REPAIR AND REGENERATION MARKET SNAPSHOT
TABLE 56 NORTH AMERICA: CARTILAGE REPAIR AND REGENERATION MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 57 NORTH AMERICA: CARTILAGE REPAIR AND REGENERATION MARKET, BY TREATMENT MODALITY, 2018–2025 (USD MILLION)
TABLE 58 NORTH AMERICA: CARTILAGE REPAIR AND REGENERATION MARKET
FOR CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 59 NORTH AMERICA: CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 60 NORTH AMERICA: CARTILAGE REPAIR AND REGENERATION MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 61 NORTH AMERICA: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 62 NORTH AMERICA: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION SITE, 2018–2025(USD MILLION)
10.2.1 US
10.2.1.1 Increasing incidence of obesity is the major factor supporting the market growth in the US
TABLE 63 US: CARTILAGE REPAIR AND REGENERATION MARKET, BY TREATMENT MODALITY, 2018–2025 (USD MILLION)
TABLE 64 US: CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 65 US: CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 66 US: CARTILAGE REPAIR AND REGENERATION MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 67 US: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 68 US: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION SITE, 2018–2025 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Increasing investments in regenerative medicine research to drive market growth
TABLE 69 CANADA: CARTILAGE REPAIR AND REGENERATION MARKET, BY TREATMENT MODALITY, 2018–2025 (USD MILLION)
TABLE 70 CANADA: CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 71 CANADA: CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 72 CANADA: CARTILAGE REPAIR AND REGENERATION MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 73 CANADA: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 74 CANADA: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION SITE, 2018–2025 (USD MILLION)
10.3 EUROPE
TABLE 75 EUROPE: CARTILAGE REPAIR AND REGENERATION MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 76 EUROPE: CARTILAGE REPAIR AND REGENERATION MARKET, BY TREATMENT MODALITY, 2018–2025 (USD MILLION)
TABLE 77 EUROPE: CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 78 EUROPE: CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 79 EUROPE: CARTILAGE REPAIR AND REGENERATION MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 80 EUROPE: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 81 EUROPE: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION SITE, 2018–2025 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Strong R&D base and focus on minimally invasive surgeries to support market growth
TABLE 82 GERMANY: CARTILAGE REPAIR AND REGENERATION MARKET, BY TREATMENT MODALITY, 2018–2025 (USD MILLION)
TABLE 83 GERMANY: CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 84 GERMANY: CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 85 GERMANY: CARTILAGE REPAIR AND REGENERATION MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 86 GERMANY: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 87 GERMANY: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION SITE, 2018–2025 (USD MILLION)
10.3.2 UK
10.3.2.1 Rising number of clinical trials in the UK to drive market growth
TABLE 88 UK: CARTILAGE REPAIR AND REGENERATION PRODUCTS UNDER CLINICAL TRIALS
TABLE 89 UK: CARTILAGE REPAIR AND REGENERATION MARKET, BY TREATMENT MODALITY, 2018–2025 (USD MILLION)
TABLE 90 UK: CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 91 UK: CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 92 UK: CARTILAGE REPAIR AND REGENERATION MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 93 UK: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 94 UK: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION SITE, 2018–2025 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 Rising healthcare expenditure in the country to drive market growth
TABLE 95 FRANCE: CARTILAGE REPAIR AND REGENERATION MARKET, BY TREATMENT MODALITY, 2018–2025 (USD MILLION)
TABLE 96 FRANCE: CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 97 FRANCE: CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 98 FRANCE: CARTILAGE REPAIR AND REGENERATION MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 99 FRANCE: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 100 FRANCE: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION SITE, 2018–2025 (USD MILLION)
10.3.4 REST OF EUROPE
TABLE 101 ROE: CARTILAGE REPAIR AND REGENERATION MARKET, BY TREATMENT MODALITY, 2018–2025 (USD MILLION)
TABLE 102 ROE: CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 103 ROE: CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 104 ROE: CARTILAGE REPAIR AND REGENERATION MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 105 ROE: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 106 ROE: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION SITE, 2018–2025 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 29 ASIA PACIFIC: CARTILAGE REPAIR AND REGENERATION MARKET
TABLE 107 APAC: CARTILAGE REPAIR AND REGENERATION MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 108 APAC: CARTILAGE REPAIR AND REGENERATION MARKET, BY TREATMENT MODALITY, 2018–2025 (USD MILLION)
TABLE 109 APAC: CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 110 APAC: CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 111 APAC: CARTILAGE REPAIR AND REGENERATION MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 112 APAC: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 113 APAC: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION SITE, 2018–2025 (USD MILLION)
10.4.1 JAPAN
10.4.1.1 Rising geriatric population is the major factor supporting market growth in Japan
TABLE 114 JAPAN: CARTILAGE REPAIR AND REGENERATION MARKET, BY TREATMENT MODALITY, 2018–2025 (USD MILLION)
TABLE 115 JAPAN: CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 116 JAPAN: CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 117 JAPAN: CARTILAGE REPAIR AND REGENERATION MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 118 JAPAN: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 119 JAPAN: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION SITE, 2018–2025 (USD MILLION)
10.4.2 CHINA
10.4.2.1 China forms the fastest-growing market in the APAC
TABLE 120 CHINA: CARTILAGE REPAIR AND REGENERATION MARKET, BY TREATMENT MODALITY, 2018–2025 (USD MILLION)
TABLE 121 CHINA: CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 122 CHINA: CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 123 CHINA: CARTILAGE REPAIR AND REGENERATION MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 124 CHINA: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 125 CHINA: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION SITE, 2018–2025 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Medical tourism will propel market growth in India
TABLE 126 INDIA: CARTILAGE REPAIR AND REGENERATION MARKET, BY TREATMENT MODALITY, 2018–2025 (USD MILLION)
TABLE 127 INDIA: CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 128 INDIA: CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 129 INDIA: CARTILAGE REPAIR AND REGENERATION MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 130 INDIA: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 131 INDIA: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION SITE, 2018–2025 (USD MILLION)
10.4.4 REST OF ASIA PACIFIC
TABLE 132 ROAPAC: CARTILAGE REPAIR AND REGENERATION MARKET, BY TREATMENT MODALITY, 2018–2025 (USD MILLION)
TABLE 133 ROAPAC: CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 134 ROAPAC: CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 135 ROAPAC: CARTILAGE REPAIR AND REGENERATION MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 136 ROAPAC: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 137 ROAPAC: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION SITE, 2018–2025 (USD MILLION)
10.5 REST OF THE WORLD
TABLE 138 ROW: CARTILAGE REPAIR AND REGENERATION MARKET, BY TREATMENT MODALITY, 2018–2025 (USD MILLION)
TABLE 139 ROW: CARTILAGE REPAIR AND REGENERATION MARKET FOR CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 140 ROW: CARTILAGE REPAIR AND REGENERATION MARKET FOR NON-CELL-BASED APPROACHES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 141 ROW: CARTILAGE REPAIR AND REGENERATION MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 142 ROW: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 143 ROW: CARTILAGE REPAIR AND REGENERATION MARKET, BY APPLICATION SITE, 2018–2025 (USD MILLION)
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 MARKET RANKING ANALYSIS
FIGURE 30 CARTILAGE REPAIR AND REGENERATION MARKET RANKING, 2019
11.2.1 MARKET REVENUE ANALYSIS (2015–2019)
FIGURE 31 REVENUE ANALYSIS OF MAJOR PLAYERS (2015?2019)
11.3 MARKET EVALUATION FRAMEWORK
TABLE 144 MARKET EVALUATION FRAMEWORK: PRODUCT LAUNCH—THE MAJOR STRATEGY ADOPTED BY PLAYERS
11.4 COMPETITIVE SCENARIO
11.4.1 KEY PRODUCT LAUNCHES
11.4.2 KEY ACQUISITIONS
11.4.3 KEY COLLABORATIONS
11.4.4 KEY EXPANSIONS
11.5 COMPANY EVALUATION MATRIX
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PARTICIPANTS
11.5.4 PERVASIVE
FIGURE 32 CARTILAGE REPAIR AND REGENERATION MARKET:
COMPETITIVE EVALUATION MATRIX (2019)
12 COMPANY PROFILES
(Business overview, Products offered, Recent Developments, SWOT analysis, MNM view)*
12.1 SMITH & NEPHEW PLC
FIGURE 33 SMITH & NEPHEW: COMPANY SNAPSHOT (2019)
12.2 DEPUY SYNTHES
FIGURE 34 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2019)
12.3 ZIMMER BIOMET HOLDINGS, INC.
FIGURE 35 ZIMMER BIOMET: COMPANY SNAPSHOT (2019)
12.4 STRYKER CORPORATION
FIGURE 36 STRYKER CORPORATION: COMPANY SNAPSHOT (2019)
12.5 VERICEL CORPORATION
FIGURE 37 VERICEL CORPORATION: COMPANY SNAPSHOT (2019)
12.6 B. BRAUN MELSUNGEN AG
FIGURE 38 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2019)
12.7 ANIKA THERAPEUTICS
FIGURE 39 ANIKA THERAPEUTICS: COMPANY SNAPSHOT (2019)
12.8 RTI SURGICAL
12.9 CONMED CORPORATION
FIGURE 40 CONMED CORPORATION: COMPANY SNAPSHOT (2019)
12.10 ARTHREX, INC.
12.11 REGROW BIOSCIENCES
12.12 MEDIPOST
FIGURE 41 MEDIPOST: COMPANY SNAPSHOT (2019)
12.13 GEISTLICH PHARMA AG
12.14 ALLOSOURCE
12.15 ORTHOCELL LTD.
12.16 BIOTISSUE SA
*Details on Business overview, Products offered, Recent Developments, SWOT analysis, MNM view might not be captured in case of unlisted companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
